These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26722646)

  • 21. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
    Dounousi E; Mitsis M; Naka KK; Pappas C; Lakkas L; Harisis C; Pappas K; Koutlas V; Tzalavra I; Spanos G; Michalis LK; Siamopoulos KC
    Transplant Proc; 2014 Nov; 46(9):3194-8. PubMed ID: 25420857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study.
    Yepes-Calderón M; Sotomayor CG; Gans ROB; Berger SP; Leuvenink HGD; Tsikas D; Rodrigo R; Navis GJ; Bakker SJL
    Nephrol Dial Transplant; 2020 Mar; 35(3):512-519. PubMed ID: 32133530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Cardiovascular Risk in Renal Transplant Recipients: Preliminary Results.
    Heleniak Z; Komorowska-Jagielska K; Dębska-Ślizień A
    Transplant Proc; 2018; 50(6):1813-1817. PubMed ID: 30056906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Sladoje-Martinovic B; Orlic L
    Kidney Blood Press Res; 2014; 39(4):308-14. PubMed ID: 25300437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant.
    Taber DJ; Pilch NA; Meadows HB; McGillicuddy JW; Bratton CF; Chavin KD; Baliga PK; Egede LE
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):243-50. PubMed ID: 23258931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk in renal transplant recipients.
    Devine PA; Courtney AE; Maxwell AP
    J Nephrol; 2019 Jun; 32(3):389-399. PubMed ID: 30406606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consumption of fruits and vegetables and cardiovascular mortality in renal transplant recipients: a prospective cohort study.
    Sotomayor CG; Gomes-Neto AW; Eisenga MF; Nolte IM; Anderson JLC; de Borst MH; Osté MCJ; Rodrigo R; Gans ROB; Berger SP; Navis GJ; Bakker SJL
    Nephrol Dial Transplant; 2020 Feb; 35(2):357-365. PubMed ID: 30165500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
    Handelsman Y
    Adv Ther; 2019 Oct; 36(10):2567-2586. PubMed ID: 31444707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease in renal transplant recipients.
    McQuarrie EP; Fellström BC; Holdaas H; Jardine AG
    J Ren Care; 2010 May; 36 Suppl 1():136-45. PubMed ID: 20586909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes and cardiovascular disease following kidney transplantation.
    Boerner BP; Shivaswamy V; Desouza CV; Larsen JL
    Curr Diabetes Rev; 2011 Jul; 7(4):221-34. PubMed ID: 21644915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease: Risk factors and applicability of a risk model in a Greek cohort of renal transplant recipients.
    Anastasopoulos NA; Dounousi E; Papachristou E; Pappas C; Leontaridou E; Savvidaki E; Goumenos D; Mitsis M
    World J Transplant; 2017 Feb; 7(1):49-56. PubMed ID: 28280695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasculogenic erectile dysfunction in renal transplant recipients--assessment of potential risk factors.
    El-Assmy A; El-Bahnasawy MS; Dawood A; AboBieh E; Ali-El Dein B; El-Dein AB; El-Hamady Sel-D
    Scand J Urol Nephrol; 2004; 38(6):511-6. PubMed ID: 15841788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High plasma hemopexin activity is an independent risk factor for late graft failure in renal transplant recipients.
    Krikken JA; van Ree RM; Klooster A; Seelen MA; Borghuis T; Lems SP; Schouten JP; Bakker WW; Gans RO; Navis G; Bakker SJ
    Transpl Int; 2010 Aug; 23(8):805-12. PubMed ID: 20149159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
    Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
    JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.
    Taber DJ; Hunt KJ; Fominaya CE; Payne EH; Gebregziabher M; Srinivas TR; Baliga PK; Egede LE
    Hypertension; 2016 Sep; 68(3):715-25. PubMed ID: 27402921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease.
    Meier-Kriesche HU; Schold JD; Srinivas TR; Reed A; Kaplan B
    Am J Transplant; 2004 Oct; 4(10):1662-8. PubMed ID: 15367222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.
    Cole AJ; Johnson RW; Egede LE; Baliga PK; Taber DJ
    Contemp Clin Trials Commun; 2018 Mar; 9():1-6. PubMed ID: 29532038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.